Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer-Reference-Cited by-同舟云学术

Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer

Published:2023-07-05 Issue:7 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Newhouse Rebecca¹,Nelissen Ellen²,El-Shakankery Karim Hussien³,Rogozińska Ewelina⁴,Bain Esme⁵,Veiga Susana⁵,Morrison Jo¹

Affiliation:

1. Department of Gynaecological Oncology; Musgrove Park Hospital; Taunton UK

2. Department of Gynaecological Oncology; The Royal Marsden; London UK

3. Medical Oncology; University College London Hospitals NHS Trust; London UK

4. The Evidence-Based Medicine Consultancy Ltd; Bath UK

5. Department of Gynaecological Oncology; North Bristol NHS Trust; Bristol UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference277 articles.

1. Apatinib combined with pegylated liposomal doxorubicin (PLD) versus PLD for platinum-resistant recurrent ovarian cancer (APPROVE): a multicenter, randomized, controlled, open-label, phase II trial;Wang;Gynecologic Oncology

2. TLK286 (telcyta) in combination with carboplatin (paraplatin) versus doxil in platinum refractory or resistant ovarian cancer clinicalTrails.gov 2005

3. Phase 3 Study: Canfosfamide (C, TLK286) plus carboplatin (P) vs liposomal doxorubicin (D) as 2nd line therapy of platinum (P) resistant ovarian cancer (OC);Rose;Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I,2007

4. Randomised phase III study of canfosfamide (TLK 286) plus pegylated liposomal doxorubicin (PLD) vs PLD as second-line therapy in platinum (P) refractory or resistant ovarian cancer (OC);Vergote;Journal of Clinical Oncology,2009

5. Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer;Vergote;International Journal of Gynecological Cancer,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Achieving Precision Healthcare through Nanomedicine and Enhanced Model Systems;ACS Materials Au;2023-12-18

2. What are the effects of pegylated liposomal doxorubicin (PLD) for women with platinum-sensitive or platinum-resistant relapsed epithelial ovarian cancer?;Cochrane Clinical Answers;2023-09-12